Clinical characteristic | NSCLC (n = 100) | Control (n = 100) | P |
---|---|---|---|
Age | |||
<60 | 49(51.6 %) | 46(48.4 %) | 0.706 |
≥60 | 51(48.6 %) | 54(51.4 %) | |
Gender | |||
Male | 65(48.1 %) | 70(51.9 %) | 0.538 |
Female | 35(53.8 %) | 30(46.2 %) | |
Smoking status | |||
Current | 32(45.7 %) | 38(54.3 %) | 0.624 |
Former | 53(52.5 %) | 48(47.5 %) | |
Never | 15(51.7 %) | 14(48.3 %) | |
TNM stage | |||
Stages I–II | 57 | – | – |
Stage III | 43 | – | – |
Differentiation | |||
G1 + G2 | 55 | – | – |
G3 | 45 | – | – |
Lymph node metastasis | |||
Negative | 37 | – | – |
Positive | 63 | – | – |
Histological type | |||
Adenocarcinoma | 44 | – | – |
Squamous carcinoma | 46 | – | – |
Others | 10 | – | – |